{"id":49595,"date":"2022-10-13T16:01:54","date_gmt":"2022-10-13T14:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/"},"modified":"2022-10-13T16:01:54","modified_gmt":"2022-10-13T14:01:54","slug":"advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/","title":{"rendered":"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5656209\/advancements-in-mirna-technology-assessment?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=qw2vgm&amp;utm_campaign=1762023+-+Advancements+in+miRNA+Report+2022%3A+Improved+Targeted+Delivery+Systems+to+Reduce+Off-target+Effects+and+Toxicity&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Advancements in miRNA: Technology Assessment&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/21\/logo.jpg\"><\/a><\/p>\n<p>\nAccelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical validation of miRNA diagnostic tests has created several opportunities for miRNA diagnostic companies. The role of miRNAs as circulating biomarkers makes it possible to perform diagnostics from body fluids. The potential of miRNA biomarkers in identifying diseases like thyroid cancer, breast cancer, and ovarian cancer is being explored.\n<\/p>\n<p>\nmiRNA diagnostics is expected to grow further and become prominent in point-of-care diagnostics. The development of miRNA therapeutics has had its challenges with respect to stability and delivery issues. However, newer approaches in the development of antagomiRs (miRNA inhibiting drugs) and agomiRs (miRNA replacement therapy) have shown promising results. miRNA companies have witnessed a highly competitive ecosystem and have been acquired by several larger pharma and diagnostics companies upon their entry into the clinical trial stage.\n<\/p>\n<p>\nThis study focuses on the developments in miRNA therapeutics and diagnostics. It identifies the factors driving interest in miRNA research as well as those affecting the commercialization of miRNA therapeutics and diagnostics. The report also discusses the emerging opportunities for miRNA technology companies and highlights investment prospects for industry participants and stakeholders.\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Strategic Imperatives<\/strong>\n<\/p>\n<ul>\n<li>\nWhy Is It Increasingly Difficult to Grow? The Strategic Imperative 8: Factors Creating Pressure on miRNA Technology Growth\n<\/li>\n<li>\nThe Strategic Imperative 8\n<\/li>\n<li>\nThe Impact of the Top 3 Strategic Imperatives on the Micro Ribonucleic Acid (miRNA) Industry\n<\/li>\n<li>\nGrowth Opportunities Fuel the Growth Pipeline Engine\n<\/li>\n<li>\nResearch Methodology\n<\/li>\n<\/ul>\n<p>\n<strong>2. Growth Opportunity Analysis<\/strong>\n<\/p>\n<ul>\n<li>\nScope of Analysis\n<\/li>\n<li>\nSegmentation\n<\/li>\n<li>\nGrowth Drivers\n<\/li>\n<li>\nGrowth Restraints\n<\/li>\n<\/ul>\n<p>\n<strong>3. Assessment of miRNA Therapeutics Landscape: Introduction<\/strong>\n<\/p>\n<ul>\n<li>\nEmerging Trends in miRNA Therapeutics and Diagnostics\n<\/li>\n<li>\nIncreasing Research in miRNA Therapeutics and Diagnostics\n<\/li>\n<li>\nmiRNA Drugs Experiencing Rapid Strides in Clinical Development\n<\/li>\n<li>\nEnablers Accelerating miRNA Research and Commercial Development\n<\/li>\n<li>\nIntroduction to miRNA Therapeutics\n<\/li>\n<li>\nmiRNA Therapeutics to Address Complex Diseases\n<\/li>\n<li>\nEvolving Approaches in Developing Antagomirs and miRNA Mimics\n<\/li>\n<li>\nStructural Modifications to Increase miRNA Stability\n<\/li>\n<\/ul>\n<p>\n<strong>4. Assessment of miRNA Therapeutics Landscape: Application<\/strong>\n<\/p>\n<ul>\n<li>\nApplication of miRNAs in Diseases\n<\/li>\n<li>\nOncology\n<\/li>\n<li>\nRespiratory Diseases\n<\/li>\n<li>\nNeurology\n<\/li>\n<li>\nCardiovascular Diseases\n<\/li>\n<li>\nOther Diseases\n<\/li>\n<li>\nmiRNA Therapeutics in Development by Companies\n<\/li>\n<li>\nIncreasing miRNA Research Activities in Academia\n<\/li>\n<\/ul>\n<p>\n<strong>5. Assessment of miRNA Therapeutics Landscape: Delivery and Stability<\/strong>\n<\/p>\n<ul>\n<li>\nChallenges in miRNA Therapeutics\n<\/li>\n<li>\nImportant miRNA Therapeutics Delivery Systems\n<\/li>\n<li>\nComparison of miRNA Delivery Systems\n<\/li>\n<li>\nDeveloping Newer Delivery Systems\n<\/li>\n<li>\nFuture Prospects of miRNA Therapeutics\n<\/li>\n<\/ul>\n<p>\n<strong>6. Assessment of miRNA Diagnostics Landscape: Introduction<\/strong>\n<\/p>\n<ul>\n<li>\nIntroduction to miRNA Diagnostics\n<\/li>\n<li>\nBenefits of miRNA Diagnostics\n<\/li>\n<li>\nOpportunities for Using miRNA in Diagnostics\n<\/li>\n<li>\nEmerging Developments in miRNA Diagnostics\n<\/li>\n<\/ul>\n<p>\n<strong>7. Assessment of miRNA Diagnostics Landscape: Application<\/strong>\n<\/p>\n<ul>\n<li>\nOncology\n<\/li>\n<li>\nNeurological Diseases\n<\/li>\n<li>\nCardiovascular and Other Diseases\n<\/li>\n<\/ul>\n<p>\n<strong>8. Assessment of miRNA Therapeutics &amp; Diagnostics: Funding Landscape<\/strong>\n<\/p>\n<ul>\n<li>\nM&amp;A miRNA Therapeutics\n<\/li>\n<li>\nM&amp;A miRNA Diagnostics\n<\/li>\n<li>\nFunding Landscape of miRNA companies\n<\/li>\n<li>\nmiRNA &#8211; Important Takeaways\n<\/li>\n<\/ul>\n<p>\n<strong>9. Growth Opportunity Universe<\/strong>\n<\/p>\n<ul>\n<li>\nGrowth Opportunity 1: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity\n<\/li>\n<li>\nGrowth Opportunity 2: Development of POC Diagnostics to Detect Circulating Biomarkers Across Diseases\n<\/li>\n<li>\nGrowth Opportunity 3: Companion Diagnostics for Precision Medicine\n<\/li>\n<\/ul>\n<p>\n<strong>10. Appendix<\/strong>\n<\/p>\n<ul>\n<li>\nTechnology Readiness Levels (TRL): Explanation\n<\/li>\n<li>\nFunding Landscape for miRNA Therapeutics\n<\/li>\n<li>\nFunding Landscape for miRNA Diagnostics\n<\/li>\n<\/ul>\n<p>\n<strong>11. Next Steps<\/strong>\n<\/p>\n<ul>\n<li>\nYour Next Steps\n<\/li>\n<li>\nWhy Now?\n<\/li>\n<li>\nLegal Disclaimer\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5656209\/advancements-in-mirna-technology-assessment?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=qw2vgm&amp;utm_campaign=1762023+-+Advancements+in+miRNA+Report+2022%3A+Improved+Targeted+Delivery+Systems+to+Reduce+Off-target+Effects+and+Toxicity&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/23m7da<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"mail&#116;&#111;&#58;&#112;&#114;&#101;&#115;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;hand&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#x2e;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#64;&#114;&#101;&#115;ear&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#97;&#114;&#107;ets&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Advancements in miRNA: Technology Assessment&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49595","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Advancements in miRNA: Technology Assessment&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-13T14:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-13T14:01:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/\"},\"wordCount\":609,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005721\\\/en\\\/1601377\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/\",\"name\":\"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005721\\\/en\\\/1601377\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-13T14:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005721\\\/en\\\/1601377\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005721\\\/en\\\/1601377\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Advancements in miRNA: Technology Assessment&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Accelerated research around RNA-based therapeutics and diagnostics, accompanied by technology advancements in sequencing the human genome, has resulted in a better understanding of the role of miRNA in biological pathways, enhancing its potential in both therapeutics and diagnostics. The successful clinical ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-13T14:01:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity &#8211; ResearchAndMarkets.com","datePublished":"2022-10-13T14:01:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/"},"wordCount":609,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/","name":"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/21\/logo.jpg","datePublished":"2022-10-13T14:01:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221013005721\/en\/1601377\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/advancements-in-mirna-report-2022-improved-targeted-delivery-systems-to-reduce-off-target-effects-and-toxicity-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Advancements in miRNA Report 2022: Improved Targeted Delivery Systems to Reduce Off-target Effects and Toxicity &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49595"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49595\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}